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ABSTRACT 
Objective: Sophorolipids (SLs) are glycolipid biosurfactants that have been shown to have anticancer activity. We investigated the anti-cancer 
activity of cetyl alcohol sophorolipids (CAS) and oleic acid sophorolipids (OAS) in breast cancer (MCF-7, MDA-MB-231), cervical cancer (SiHa, HeLa) 
and non-cancerous (HaCaT and RAW264.7) cell lines. 
Methods: For cell viability assay, MCF-7, MDA-MB-231, SiHa, HeLa, HaCaT and RAW264.7 cell lines were treated with different concentrations (0-
160 µg/ml) of OAS and CAS for 24h. The cell viability was determined by MTT dye uptake method. Cell proliferation assay was determined by using 
trypan blue dye exclusion method. 
Results: Our preliminary data shows that compared to OAS, CAS exhibited more significant reduction in the viability of MCF-7, MDA-MB-231 and 
SiHa. However, compared to CAS, OAS induced more decrease in viability in HeLa cells. Interestingly, both the types of SLs did not affect the viability 
of non-cancerous cells. Moreover, CAS, when used as a coating material, induced proliferation in macrophage cell line, RAW264.7. 
Conclusion: The present study provides an important clue towards the anti-cancer potential of OAS and CAS derived from Candida bombicola. 
Interestingly, the ability of CAS to promote the proliferation of non-cancerous cells suggests its future application as a scaffold for enhancing the 
adhesion and proliferation of normal cells. 
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Biosurfactants, derived from non-pathogenic organisms, are 
extensively gaining recognition due to biodegradability and reduced 
environmental impact compared to the chemical surfactants that 
cause the detrimental effect on the environment due to 
bioaccumulation and eutrophication [1]. The sophorolipids (SLs) are 
biosurfactants belonging to the glycolipids class, produced by many 
non-pathogenic yeasts such as Candida apicola[2], Candida 
bogoriensis [3], Wickerhamielladomercqiae [4], Pichiaanomala [5], 
Candida guilliermondii [6] and Candida bombicola [7, 8]. SLs show 
structural similarity with glycosphingolipids and gangliosides, the 
membrane components of mammalian cells, which are involved in 
processes such as signaling, oncogenesis, and differentiation [9]. SLs 
have been shown to have various pharmacological properties 
including anti-cancer activity. It has been reported that natural 
mixture of SLs or select derivatives [ethyl ester, methyl ester, ethyl 
ester monoacetate, ethyl ester diacetate, acidic sophorolipid, lactonic 
sophorolipid diacetate] could induce necrosis in human pancreatic 
carcinoma cells. SLs produced by Candida bombicola NRRL Y-17069 
have been shown to exhibit anticancer activity against 
hepatocellular carcinoma (HepG2) and lung cancer (A549) cell lines 
[10]. SLs with one double bond in fatty acid part in their structure 
have been reported to have the potent cytotoxic effect on esophageal 
cancer cell lines (KYSE109 and KYSE450) [11]. SLs produced by W. 
domercqiae have been demonstrated to induce cell death via 
apoptosis in human liver (H7402) and lung cancer (A549) cell lines 
[12]. We have recently reported SLs of oleic and linoleic acids in 
pure acidic and crude forms could induce differentiation in LN-229, 
a glioma cell line [9]. 
Recently, we have reported the use of cetyl alcohol as the lipophilic 
carbon feed source for Candida bombicola (ATCC 22214) that was 
incorporated into the sophorolipid molecule synthesized by the 
yeast [13]. The effectiveness of cetyl alcohol sophorolipids (CAS) as a 
surfactant was shown by measuring its surface tension lowering 
capacity, which was found to be significantly more as compared to 
the oleic acid derived sophorolipids (OAS) [10]. The antibacterial 
activity of CAS against Staphylococcus aureus and Escherichia coli 
was found to be higher in comparison to OAS [13]. In the present 
work, we have further compared the anticancer activity of CAS and 
OAS on breast, cervical and non-cancerous cell lines. We have also 
evaluated the potential of CAS as a biocoat for tissue culture plastic 
ware that would help in attachment and proliferation of the normal 
cells. 
For in vitro assays, Dulbecco’s Modified Eagle’s Medium (DMEM), 
foetal bovine serum, penicillin/streptomycin, L-glutamine and MTT 
dye [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylthiazolium bromide] 
were procured from Sigma-Aldrich (St. Louis, MO). Tissue culture 
plasticware was purchased from BD Biosciences, CA, USA. The cell 
lines MCF-7, MDA-MB-231, SiHa, HeLa, HaCaT and RAW264.7 were 
obtained from National Centre for Cell Science (NCCS), Pune, India. 
The cells were grown in DMEM containing 2 mM L-glutamine 
supplemented with 10% fetal bovine serum and 100 U/ml of 
penicillin-streptomycin. The cells were incubated in a humidified 5% 
CO2 incubator at 37 °C. Glucose was purchased from Qualigens, 
India. Malt extract, yeast extract and peptone were procured from 
Hi-media, India. Cetyl alcohol (C16) was received as a kind gift from 
Galaxy Surfactants, India.  
The yeast used in this study was Candida bombicola ATCC 22214. It 
was grown in MGYP medium (containing 0.3% malt extract, 2% 
glucose, 0.3% yeast extract, 0.5% peptone) at 30 °C. The culture was 
maintained by periodic transfer on MGYP agar slants at 4 °C. A 
loopful of Candida bombicola ATCC 22214 cells were taken from 
plant and seed culture was developed by transferring it to 10 ml 
medium [consisting of g/l: glucose, 100; yeast extract, 1.0; 
MgSO4.7H2O, 0.3; Na2HPO4, 2; NaH2PO4, 7; (NH4)2SO4, 1], for 24 h at 
30 °C with 180 rpm orbital shaking [14]. The seed culture was 
transferred to 40 ml medium for developing the starter culture and 
incubated for 24 h at 30 °C with 180 rpm orbital shaking. The 
fermentative production was further carried out by transferring the 
starter culture into 200 ml of above-mentioned medium in 1 L 
Erlenmeyer flask and incubated for 120 h at 30 °C with 180 rpm 
orbital shaking. The medium was supplemented with cetyl alcohol as 
lipophilic substrate at the concentration of 1 g/100 ml dissolved in 
0.5 ml ethanol. 
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Candida bombicola cells were harvested from the culture broth by 
centrifugation at 5,000 rpm, 10 °C for 20 min. An equal volume of 
ethyl acetate was added to supernatant for extracting the 
sophorolipids as described elsewhere [15]. The aqueous layer was 
re-extracted until no emulsion was formed at the interface. Sodium 
sulphate was added to remove any traces of water. The solvent was 
filtered and reduced by rotary evaporation under vacuum to yield a 
brown colored viscous product that was stored at 4 °C. 
The cell viability study was performed by using MTT dye [16, 17]. 
MCF-7, MDA-MB-231, SiHa, HeLa, HaCaT and RAW264.7 cell lines 
were grown in DMEM supplemented with 2 mM L-glutamine, 100 
units/ml of penicillin/streptomycin and 10% fetal bovine serum and 
incubated in a humidified 5% CO2 atmosphere at 37 °C. The cells 
were seeded at 1×105cells/ml density in 96-well plates (Axygen TPP, 
CA, USA). After 24 h, the cells were incubated with fresh medium 
containing oleic acid sophorolipids (OAS), oleic acid (OA), cetyl 
alcohol sophorolipids (CAS) and cetyl alcohol (CA). The OAS, CAS, CA 
were added at concentrations ranging from 0-160 µg/ml whereas 
OA was added at following concentrations 2.82, 5.64, 11.29, 22.59, 
45.19 and 90.38µg/ml in each well (in triplicates). The plates were 
incubated overnight at 37 °C in 5% CO2 incubator. The MTT solution (5 
mg/ml) was added to each well, and the cells were cultured for 
another 4h at 37 °C in 5% CO2 incubator. The resulting formazan 
crystals were dissolved in 90 µl of SDS in DMF. The intensity of colored 
formazan derivative was determined by measuring optical density 
(OD) using ELISA microplate reader (Biorad, Hercules, CA) at 570 nm 
(OD570–630 nm). The mean OD value was used for assessing the cell 
viability expressed as the percentage. From the graphs of % viability 
versus concentrations, IC50 values were obtained. 
% Viability = (Treated cells/Control cells) x 100 
The non-treated polystyrene 35 mm dishes were coated with 0.1% of 
CAS, OAS and gelatin for 4 h. The excess of sophorolipids and gelatin 
was removed from the dishes. The plates were allowed to dry under 
sterile conditions. RAW264.7 cells were seeded at a density of 5x104 
cells/ml in the coated dishes. The plates were incubated overnight at 
37 °C in 5 % CO2 incubator. After 24 h, the cells were trypsinized and 
counted by using trypan blue dye exclusion method [16, 17]. 
All the results were obtained from three independent experiments, 
each performed in triplicates and the values have been presented as 
mean±SD. Differences among means were tested for statistical 
significance using one-way analysis of variance (ANOVA). For 
multiple comparisons, Tukeys test was used. The analyses were 
carried out using Graph pad prism 5 software (San Diego, CA, USA). 
*p<0.05; **p<0.01; ***p<0.001 were considered to be statistically 
significant. 
Recently, there have been many reports demonstrating the usage of 
sophorolipids as novel anti-cancer agents. The sophorolipids studied 
so far have been shown to exhibit cytotoxicity against liver, lung, 
pancreatic and esophageal carcinoma cell lines, with only a few 
studies on breast cancer cell lines [14]. We have for the first time 
evaluated the inhibitory effect of OAS and CAS on the viability of 
breast cancer cell lines, MCF-7 (ER+/PR+/Her2-) and MDA-MB231 
(ER-/PR-/Her2-) by using MTT assay. Both MCF7 and MDAMB231 
cells were treated with different concentrations (0-160 μg/ml) of 
CAS and OAS for 24 h, followed by MTT assay the next day. In MCF-7, 
CAS was found to decrease the viability of cells more significantly 
than OAS with IC50 value of 151.38 μg/ml for CAS (table 1). 
Contrarily, cells treated with OAS exhibited around 96% viability up 
to 160 μg/ml dose. A recent report has demonstrated anti-cancer 
activity of Candida bombicola derived sophorolipids against 
hepatocellular carcinoma (HepG2) and lung cancer (A549) cell lines 
with no activity towards breast cancer (MCF-7) cells [14]. In 
MDAMB231 cells, we found that CAS reduced the viability of the cells 
to a higher extent (IC50 value of 82.93 μg/ml) compared to OAS. On 
the other hand, cells treated with OAS exhibited around 80% 
viability up to 160 μg/ml dose. A recent study reported that SLs 
derived from Starmerella bombicola inhibited the cell migration of 
MDA-MB-231 without compromising cell viability and also increased 
intracellular reactive oxygen species [15]. To find out whether the 
activity exhibited by OAS and CAS was sole because of the 
sophorolipids and not because of their individual substrates (OA and 
CA), we tested their effect on the viability of the cancer cells 
(Supplementary tables 1 and 2, respectively). In response to OA and 
CA, both the cell types exhibited 100% viability up to 2.8 and 160 
μg/ml dose, respectively. Interestingly, the amount of OA used in 
OAS was 0.01 μg/ml and, hence, whatever cytotoxicity was observed 
in MDA-MB231 was solely due to OAS. These results suggested that 
CAS exhibited significant anticancer activity in breast cancer cells 
compared to OAS and could be further explored for their detailed 
anti-cancer activity in vitro and in vivo. 
 
Table 1: Effect of OAS and CAS on cell viability of MCF-7 and MDAMB231 
Concentration of SLs (µg/ml) % Viability 
MCF-7 MDAMB231 
CAS OAS CAS OAS 
0 100.0±0.0 100.0±0.0 100.0±0.0 100.0±0.0 
10 84.6±7.3a 100.0±2.6b 68.1±2.2k 89.0±8.4p 
20 83.1±9.5c 96.4±3.5d 59.8±2.6l 84.9±3.5q 
40 82.7±10.7e 92.2±4.4f 57.3±3.8m 83.2±7.7r 
80 78.9±10.5g 97.6±5.3h 51.1±2.6n 82.8±10.6s 
160 64.1±19.2i 95.8±7.9j 26.1±1.9o 80.3±10.8t 
Values are represented as mean±SD of three independent experiments (n=3). OAS: oleic acid sophorolipids, CAS: cetyl alcohol sophorolipids. 
Tukey's multiple comparison test was done showing: “a” compared to “b”, p<0.05; “c” compared to “d”, p<0.01; “e” compared to “f”, p<0.001; “g” 
compared to “h”, p<0.001; “i” compared to “j”, p<0.001; “k” compared to “p”, p<0.001; “l” compared to “q”, p<0.001; “m” compared to “r”, p<0.001; 
“n” compared to “s”, p<0.001; “o” compared to “t”, p<0.001.  
 
To our knowledge, there are no reports demonstrating the 
cytotoxicity of SLs against cervical cancer. We have for the first time 
evaluated the cytotoxicity of OAS and CAS in cervical cancer cell 
lines, SiHa (HPV16+) and HeLa (HPV18+). Both the cell lines were 
treated with different concentrations (0-160 μg/ml) of CAS and OAS 
for 24 h, followed by MTT assay the next day.  
SiHa cells, upon treatment with CAS and OAS, exhibited around 81 
and 96% viability, respectively, at 160 μg/ml concentration (table 
2). On the other hand, HeLa cells, upon treatment with CAS and OAS, 
exhibited 53.6 and 3.7% viability at 160μg/ml concentration, 
respectively. Interestingly, IC50 values of CAS and OAS were 100.55and 
22.84μg/ml, respectively, in HeLa cells suggesting that OAS was more 
toxic to HeLa cells at lower doses. Further, to find out whether the 
activity exhibited by OAS and CAS was not because of their individual 
substrates (OA and CA), we tested their effect on the viability of the 
cervical cancer cells (Supplementary tables 1 and 2, respectively). We 
found that SiHa and HeLa cells showed95 and 70% viability up to 
160μg/ml concentration of CA, respectively, and100% viability up to 
5.64 μg/ml dose of OA (Supplementary table 2). As discussed before, 
the amount of OA used in OAS was 0.01μg/ml and hence, the 
cytotoxicity observed in SiHa and HeLa cells was solely due to OAS. 
Thus, from the above preliminary results, it could be concluded that 
CAS effectively reduced the viability of both the breast and cervical 
cancer cell lines and thus could be further explored for its 
antineoplastic potential to understand the underlying signal 
transduction mechanisms at in-vitro and in vivo levels. After 
evaluating the effect of SLs on the viability of cancerous cell lines, we 
wanted to find out whether they were toxic to the non-cancerous 
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cells or not. We treated HaCaT cells with different concentrations (0-
160 μg/ml) of CAS and OAS for 24 h, followed by MTT assay the next 
day. Both the SLs were non-toxic to HaCaT cells up to 160 µg/ml 
dose (fig. 1). 
 
Table 2: Effect of OAS and CAS on cell viability of SiHa and HeLa 
Concentration of SPLs (µg/ml) % Viability 
SiHa HeLa 
CAS OAS CAS OAS 
C 100.0±0.0 100.0±0.0 100.0±0.0 100.0±0.0 
10 96.4±2.7a 100.0±15.2b 95.1±4.6k 89.3±3.8p 
20 87.3±8.6c 100.0±3.7d 93.5±4.9l 62.3±10.5q 
40 84.4±11.3e 100.0±7.5f 92.6±1.8m 19.6±7.7r 
80 83.9±9.1g 100.0±3.6h 71.7±0.8n 15.3±3.5s 
160 81.1±12.4i 96.0±2.1j 53.6±2.5o 3.7±3.1t 
Values are represented as mean±SD of three independent experiments (n=3). OAS: oleic acid sophorolipids, CAS: cetyl alcohol sophorolipids. 
Tukey's multiple comparisons tests was done showing: “a” compared to “b”, p>0.05NS; “c” compared to “d”, p<0.01; “e” compared to “f”, p<0.05; “g” 
compared to “h”, p<0.01; “i” compared to “j”, p>0.05NS (Not significant); “k” compared to “b”, p>0.05NS; “l” compared to “q”, p<0.001; “m” compared 
to “r”, p<0.001; “n” compared to “s”, p<0.001; “o” compared to “t”, p<0.001 
 
 
Fig. 1: Effect of OAS and CAS on the viability of HaCaT cells. All 
the data are presented as mean±SD of five independent 
experiments (n=5) at p<0.001, indicating statistically 
significant differences compared to the control untreated 
group. OAS: oleic acid sophorolipids, CAS: cetyl alcohol 
sophorolipids 
 
Upon treatment of the cells with individual substrates, OA and CA, 
they exhibited 100% viability up to 22.59and 160μg/ml doses, 
respectively (Supplementary Tables 1 and 2). Since CAS showed 
more promising results in both breast and cervical cancer cell lines, 
we further evaluated its effect on the viability and proliferation of 
non-cancerous macrophage cell line, RAW 264.7.  
The cells exhibited around 91% viability in response to CAS up to a 
higher dose of 160 μg/ml (fig. 2). 
Interestingly, in the proliferation assay, we found that compared 
to either uncoated or gelatin coated wells, CAS treated wells 
increased the proliferation of RAW264.7 cells significantly (fig. 
3A). However, upon coating of cancerous cell lines, MCF-7 (fig. 3B) 
and SiHa (fig. 3C), on CAS coated wells, they showed a slight 
decrease in proliferation, compared to either uncoated or gelatin 
coated wells. 
 Recently, we have demonstrated the use of silk fibroin 
sophorolipids (SF-SL) as novel scaffolds for promoting the growth of 
mouse fibroblast cells in vitro [18]. 
 
Fig. 2: Effect of CAS on the viability of RAW264.7 cells. All the 
data are presented as mean±SD of five independent 
experiments (n=5) at p<0.001, indicating statistically 
significant differences compared to the control untreated 
group. CAS: cetyl alcohol sophorolipids 
 
 
Fig. 3: Effect of CAS on the proliferation of (A) RAW264.7, (B) 
MCF-7 and (C) SiHa. All the data are presented as mean±SD of 
three independent experiments (n=3), indicating statistically 
significant differences compared to the untreated control 
group. *p<0.05, **p<0.01, *** p<0.001 indicated statistically 
significant differences. CAS: cetyl alcohol sophorolipids 
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However, since this is a preliminary work, it requires extensive 
experimentation and comparisons with other coating materials to 
ascertain its future application as scaffolds for growing of primary cell 
cultures. The present study has explored the anti-cancer potential of 
oleic acid and cetyl alcohol sophorolipids derived from Candida 
bombicola that could be studied in detail in the future. The selectivity 
of these sophorolipids towards the cancerous cells invites attention 
towards their usefulness as adjuncts to current therapeutic modalities 
in cancer. Moreover, the property of cetyl alcohol sophorolipids in 
promoting the growth of non-cancerous cells could find applications as 
scaffolds in tissue culture, tissue regeneration, and wound healing. 
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